1207 related articles for article (PubMed ID: 26517154)
1. Immune dysfunction in cirrhosis: Distinct cytokines phenotypes according to cirrhosis severity.
Dirchwolf M; Podhorzer A; Marino M; Shulman C; Cartier M; Zunino M; Paz S; Muñoz A; Bocassi A; Gimenez J; Di Pietro L; Romero G; Fainboim H; Fainboim L
Cytokine; 2016 Jan; 77():14-25. PubMed ID: 26517154
[TBL] [Abstract][Full Text] [Related]
2. Single-centre validation of the EASL-CLIF consortium definition of acute-on-chronic liver failure and CLIF-SOFA for prediction of mortality in cirrhosis.
Silva PE; Fayad L; Lazzarotto C; Ronsoni MF; Bazzo ML; Colombo BS; Dantas-Correa EB; Narciso-Schiavon JL; Schiavon LL
Liver Int; 2015 May; 35(5):1516-23. PubMed ID: 24840673
[TBL] [Abstract][Full Text] [Related]
3. Chronic liver failure-consortium acute-on-chronic liver failure and acute decompensation scores predict mortality in Brazilian cirrhotic patients.
Picon RV; Bertol FS; Tovo CV; de Mattos ÂZ
World J Gastroenterol; 2017 Jul; 23(28):5237-5245. PubMed ID: 28811718
[TBL] [Abstract][Full Text] [Related]
4. Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated Cirrhosis.
Trebicka J; Amoros A; Pitarch C; Titos E; Alcaraz-Quiles J; Schierwagen R; Deulofeu C; Fernandez-Gomez J; Piano S; Caraceni P; Oettl K; Sola E; Laleman W; McNaughtan J; Mookerjee RP; Coenraad MJ; Welzel T; Steib C; Garcia R; Gustot T; Rodriguez Gandia MA; Bañares R; Albillos A; Zeuzem S; Vargas V; Saliba F; Nevens F; Alessandria C; de Gottardi A; Zoller H; Ginès P; Sauerbruch T; Gerbes A; Stauber RE; Bernardi M; Angeli P; Pavesi M; Moreau R; Clària J; Jalan R; Arroyo V
Front Immunol; 2019; 10():476. PubMed ID: 30941129
[No Abstract] [Full Text] [Related]
5. Characteristics, Diagnosis and Prognosis of Acute-on-Chronic Liver Failure in Cirrhosis Associated to Hepatitis B.
Li H; Chen LY; Zhang NN; Li ST; Zeng B; Pavesi M; Amorós À; Mookerjee RP; Xia Q; Xue F; Ma X; Hua J; Sheng L; Qiu DK; Xie Q; Foster GR; Dusheiko G; Moreau R; Gines P; Arroyo V; Jalan R
Sci Rep; 2016 May; 6():25487. PubMed ID: 27146801
[TBL] [Abstract][Full Text] [Related]
6. CLIF-SOFA scoring system accurately predicts short-term mortality in acutely decompensated patients with alcoholic cirrhosis: a retrospective analysis.
Lee M; Lee JH; Oh S; Jang Y; Lee W; Lee HJ; Yoo JJ; Choi WM; Cho YY; Cho Y; Lee DH; Lee YB; Yu SJ; Yi NJ; Lee KW; Kim YJ; Yoon JH; Suh KS; Lee HS
Liver Int; 2015 Jan; 35(1):46-57. PubMed ID: 25203221
[TBL] [Abstract][Full Text] [Related]
7. The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure.
Jalan R; Pavesi M; Saliba F; Amorós A; Fernandez J; Holland-Fischer P; Sawhney R; Mookerjee R; Caraceni P; Moreau R; Ginès P; Durand F; Angeli P; Alessandria C; Laleman W; Trebicka J; Samuel D; Zeuzem S; Gustot T; Gerbes AL; Wendon J; Bernardi M; Arroyo V;
J Hepatol; 2015 Apr; 62(4):831-40. PubMed ID: 25463539
[TBL] [Abstract][Full Text] [Related]
8. Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF).
Grønbæk H; Rødgaard-Hansen S; Aagaard NK; Arroyo V; Moestrup SK; Garcia E; Solà E; Domenicali M; Piano S; Vilstrup H; Møller HJ;
J Hepatol; 2016 Apr; 64(4):813-22. PubMed ID: 26639396
[TBL] [Abstract][Full Text] [Related]
9. From stable disease to acute-on-chronic liver failure: Circulating cytokines are related to prognosis in different stages of cirrhosis.
Fischer J; Silva TE; Soares E Silva PE; Colombo BS; Silva MC; Wildner LM; Bazzo ML; Rateke EC; Frode TS; Mello SV; Rosa JS; Dantas-Correa EB; Narciso-Schiavon JL; Schiavon LL
Cytokine; 2017 Mar; 91():162-169. PubMed ID: 28082235
[TBL] [Abstract][Full Text] [Related]
10. Circulating levels of pentraxin-3 (PTX3) in patients with liver cirrhosis.
Narciso-Schiavon JL; Pereira JG; Silva TE; Bansho ETO; Morato EF; Pinheiro JT; Muraro-Wildner L; Bazzo ML; Dantas-Corrêa EB; Schiavon LL
Ann Hepatol; 2017; 16(5):780-787. PubMed ID: 28809733
[TBL] [Abstract][Full Text] [Related]
11. Complications constitute a major risk factor for mortality in hepatitis B virus-related acute-on-chronic liver failure patients: a multi-national study from the Asia-Pacific region.
Chen T; Yang Z; Choudhury AK; Al Mahtab M; Li J; Chen Y; Tan SS; Han T; Hu J; Hamid SS; Huei LG; Ghazinian H; Nan Y; Chawla YK; Yuen MF; Devarbhavi H; Shukla A; Abbas Z; Sahu M; Dokmeci AK; Lesmana LA; Lesmana CRA; Xin S; Duan Z; Guo W; Ma K; Zhang Z; Cheng Q; Jia J; Sharma BC; Sarin SK; Ning Q
Hepatol Int; 2019 Nov; 13(6):695-705. PubMed ID: 31650510
[TBL] [Abstract][Full Text] [Related]
12. Chronic Liver Failure-Sequential Organ Failure Assessment is better than the Asia-Pacific Association for the Study of Liver criteria for defining acute-on-chronic liver failure and predicting outcome.
Dhiman RK; Agrawal S; Gupta T; Duseja A; Chawla Y
World J Gastroenterol; 2014 Oct; 20(40):14934-41. PubMed ID: 25356054
[TBL] [Abstract][Full Text] [Related]
13. Submassive hepatic necrosis distinguishes HBV-associated acute on chronic liver failure from cirrhotic patients with acute decompensation.
Li H; Xia Q; Zeng B; Li ST; Liu H; Li Q; Li J; Yang SY; Dong XJ; Gao T; Munker S; Liu Y; Liebe R; Xue F; Li QG; Chen XS; Liu Q; Zeng H; Wang JY; Xie Q; Meng QH; Wang JF; Mertens PR; Lammert F; Singer MV; Dooley S; Ebert MP; Qiu DK; Wang TL; Weng HL
J Hepatol; 2015 Jul; 63(1):50-9. PubMed ID: 25646889
[TBL] [Abstract][Full Text] [Related]
14. Leucocyte ratios are biomarkers of mortality in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure.
Bernsmeier C; Cavazza A; Fatourou EM; Theocharidou E; Akintimehin A; Baumgartner B; Dhar A; Auzinger G; Thursz M; Bernal W; Wendon JA; Karvellas CJ; Antoniades CG; McPhail MJW
Aliment Pharmacol Ther; 2020 Sep; 52(5):855-865. PubMed ID: 32683724
[TBL] [Abstract][Full Text] [Related]
15. Pro-adrenomedullin in acute decompensation of liver cirrhosis: relationship with acute-on-chronic liver failure and short-term survival.
Yan H; Jin S; Liang L; Du J; Aithal GP; Li L
Scand J Gastroenterol; 2020 May; 55(5):606-614. PubMed ID: 32476510
[No Abstract] [Full Text] [Related]
16. Validation of the prognostic models in acute-on-chronic liver failure precipitated by hepatic and extrahepatic insults.
Maipang K; Potranun P; Chainuvati S; Nimanong S; Chotiyaputta W; Tanwandee T; Charatcharoenwitthaya P
PLoS One; 2019; 14(7):e0219516. PubMed ID: 31291342
[TBL] [Abstract][Full Text] [Related]
17. Copeptin in acute decompensation of liver cirrhosis: relationship with acute-on-chronic liver failure and short-term survival.
Kerbert AJC; Verspaget HW; Navarro ÀA; Jalan R; Solà E; Benten D; Durand F; Ginès P; van der Reijden JJ; van Hoek B; Coenraad MJ;
Crit Care; 2017 Dec; 21(1):321. PubMed ID: 29268760
[TBL] [Abstract][Full Text] [Related]
18. Predictors of mortality among patients with compensated and decompensated liver cirrhosis: the role of bacterial infections and infection-related acute-on-chronic liver failure.
Sargenti K; Prytz H; Nilsson E; Kalaitzakis E
Scand J Gastroenterol; 2015 Jul; 50(7):875-83. PubMed ID: 25697824
[TBL] [Abstract][Full Text] [Related]
19. A nomogram for predicting prognostic value of inflammatory response biomarkers in decompensated cirrhotic patients without acute-on-chronic liver failure.
Cai YJ; Dong JJ; Dong JZ; Chen Y; Lin Z; Song M; Wang YQ; Chen YP; Shi KQ; Zhou MT
Aliment Pharmacol Ther; 2017 Jun; 45(11):1413-1426. PubMed ID: 28345155
[TBL] [Abstract][Full Text] [Related]
20. Serum sodium, model for end-stage liver disease, and a recent invasive procedure are risk factors for severe acute-on-chronic liver failure and death in cirrhotic patients hospitalized with bacterial infection.
Lopes-Secundo TM; Sevá-Pereira T; Correa BR; Silva NCM; Imbrizi MR; Cunha-Silva M; Soares EC; Almeida JRS
Eur J Gastroenterol Hepatol; 2018 Sep; 30(9):1055-1059. PubMed ID: 29944488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
